Compare Commvault Systems Inc (CVLT) vs TransMedics Group Inc (TMDX) Price & Performance

Commvault Systems (CVLT) trades at $151.00, up 0.48% on the day, with a bullish technical signal and strong analyst support. Recent quarterly earnings have consistently beaten expectations, with Q2 2026 EPS of $1.42 surpassing the $1.16 estimate. The company maintains robust profitability metrics, including an 81.09% gross margin and 32.77% ROE, though valuation ratios like a P/E of 96.73 appear elevated. Positive news includes AWS competency achievements and new board appointments, reinforcing its market position.

The outlook remains favorable given earnings momentum and institutional confidence, but high valuation multiples pose a risk if growth moderates. Revenue is projected to rise to $1.2 billion in 2026, though net margin may compress. With no sell ratings and a consensus price target of $156.55, upside potential exists, but investors should monitor competitive pressures and execution on guidance.

TMDX trades at $79.00, down 2.55% amid bearish technical signals. The stock shows strong profitability with 22.69% net margin and 36.28% ROE, though recent earnings misses and margin compression from 2025 to 2026 raise concerns. Analyst consensus remains bullish with a $99.75 price target, but multiple legal investigations into fiduciary duties create uncertainty. Revenue growth continues with 2026 guidance at $668M.

The stock presents a growth opportunity with analyst upside potential, but faces near-term headwinds from earnings volatility and legal scrutiny. Execution on 2026 guidance and resolution of governance concerns will be critical for sustained momentum. Current valuation at 20.47 P/E appears reasonable given growth prospects if operational targets are met.